Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-09-05 3:11 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 6,226,392 13.4% | 1,815,285 (+41.15%) | View |
| 2023-06-15 10:25 am Sale | 13D | PASSAGE BIO INC PASG | Frazier Life Sciences IX L.P. | 2,543,698 4.7% | -1,213,217 (-32.29%) | View |
| 2023-04-14 12:45 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 4,411,107 11.6% | 549,326 (+14.22%) | View |
| 2022-09-26 4:00 pm Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 8,424,772 21.5% | 203,448 (+2.47%) | View |
| 2022-08-16 12:20 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,861,781 10.5% | 294,869 (+8.27%) | View |
| 2022-08-15 11:29 am Sale | 13D | PASSAGE BIO INC PASG | Frazier Life Sciences IX L.P. | 3,756,915 6.9% | -1,264,523 (-25.18%) | View |
| 2022-08-11 3:55 pm Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 8,221,324 21% | 2,377,400 (+40.68%) | View |
| 2022-01-28 2:09 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Frazier Life Sciences IX L.P. | 1,417,157 6.9% | -500,000 (-26.08%) | View |
| 2021-02-04 4:35 pm Unchanged | 13G | KRYSTAL BIOTECH INC KRYS | Frazier Life Sciences IX L.P. | 895,000 4.5% | 0 (Unchanged) | View |
| 2021-01-27 2:56 pm Purchase | 13D | PASSAGE BIO INC PASG | Frazier Life Sciences IX L.P. | 5,021,438 9.5% | 12,219 (+0.24%) | View |
| 2020-12-23 1:08 pm Unchanged | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 5,843,924 18.7% | 0 (Unchanged) | View |
| 2020-12-18 12:40 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,566,912 12.2% | 0 (Unchanged) | View |
| 2020-10-23 1:40 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Frazier Life Sciences IX L.P. | 1,917,157 9.5% | 1,917,157 (New Position) | View |
| 2020-06-16 7:37 pm Sale | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 5,843,924 20.2% | -1,440,345 (-19.77%) | View |
| 2020-04-29 4:36 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,566,912 14% | 0 (Unchanged) | View |
| 2020-03-09 5:16 pm Purchase | 13D | PASSAGE BIO INC PASG | Frazier Life Sciences IX L.P. | 5,009,219 10.9% | 5,009,219 (New Position) | View |
| 2020-02-12 5:32 pm Purchase | 13G | KRYSTAL BIOTECH INC KRYS | Frazier Life Sciences IX L.P. | 895,000 5.2% | 20,000 (+2.29%) | View |
| 2019-11-06 1:50 pm Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 7,284,269 25.1% | 7,284,269 (New Position) | View |
| 2019-07-26 4:40 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,566,912 15.5% | 3,566,912 (New Position) | View |